首页 > 最新文献

Journal of Global Infectious Diseases最新文献

英文 中文
Associated Risk Factors and Clinical Outcomes of Bloodstream Infections among COVID-19 Intensive Care Unit Patients in a Tertiary Care Hospital. 一家三级医院 COVID-19 重症监护病房患者血流感染的相关风险因素和临床结果。
IF 1 Q4 INFECTIOUS DISEASES Pub Date : 2024-06-26 eCollection Date: 2024-04-01 DOI: 10.4103/jgid.jgid_108_23
Mahalakshmamma Dasarahalli Shivalingappa, Supriya Gachinmath, Shiva Kumar Narayan

Introduction: The COVID-19 infection is an ongoing public health crisis causing millions of deaths worldwide. COVID-19 patients admitted to the intensive care unit (ICU) are more vulnerable to acquire secondary bloodstream infections (sBSIs) which cause a significant morbidity and mortality. Thus, we aim to assess the risk factors of sBSIs and outcomes in COVID-19 ICU patients.

Methods: One hundred blood culture samples with growth (cases) and other 100 blood culture with no growth(controls) were collected.. All the demographic data, laboratory data and antimicrobial resistance pattern were analysed . Blood culture bottle received in the Microbiology laboratory were loaded into Automated blood culture system. Flagged bottles were processed for final identification by MALDI TOF and automated antibiotic susceptibility testing. Flagged bottles were processed for final identification by MALDI TOF and automated antibiotic susceptibility testing.

Results: Raised C-reactive protein (CRP) (P = 0.0035), interleukin-6 (P = 0.0404), mechanical ventilation (MV) (P = 0.024), prior antimicrobial exposure (P = 0.002), longer ICU stay with median 11 days (P = 0.022), and higher mortality rate (P = 0.001) were significantly associated with the BSI. A significant proportion of BSIs were Gram-negative bacteria (n = 115) such as Acinetobacter baumannii 38 (33%) and Klebsiella pneumoniae 30 (26%). Monomicrobial organisms in blood yielded a higher proportion in our study 72 (72%). The highest resistance for Acinetobacter species (50) was observed with ceftazidime 29 (96.6%) amikacin 48 (96%), meropenem 48 (96%), cefotaxime 47 (94%), ciprofloxacin 46 (92%), and netilmicin 46 (92%). K. pneumoniae was highly resistant to cefotaxime 29 (96.6%), ceftazidime 29 (96.6%), ciprofloxacin 22 (73.3%), and cefuroxime 21 (70%). Among Gram-positive organisms, Enterococcus species showed that a resistance for high-level gentamicin and penicillin was 66.6%.

Conclusions: Raised CRP, need of MV, prior antimicrobial exposure, and longer ICU stay should alarm clinicians for BSI. Hence, our study highlights the associated risk factors for BSI and emphasizes adherence to hospital infection control policies and antibiotic stewardship program.

导言:COVID-19 感染是一个持续存在的公共卫生危机,导致全球数百万人死亡。入住重症监护病房(ICU)的 COVID-19 患者更容易继发血流感染(sBSIs),从而导致严重的发病率和死亡率。因此,我们旨在评估 COVID-19 ICU 患者发生 sBSIs 的风险因素和结果:方法:收集 100 份有生长的血培养样本(病例)和 100 份无生长的血培养样本(对照)。对所有人口统计学数据、实验室数据和抗菌药耐药性模式进行了分析。微生物实验室收到的血培养瓶被装入自动血培养系统。通过 MALDI TOF 和自动抗生素药敏试验对标记瓶进行最终鉴定。通过 MALDI TOF 和自动抗生素药敏试验对标记瓶进行最终鉴定:结果:C反应蛋白(CRP)升高(P = 0.0035)、白细胞介素-6升高(P = 0.0404)、机械通气(MV)升高(P = 0.024)、既往抗菌药物暴露(P = 0.002)、ICU住院时间延长(中位 11 天)(P = 0.022)和死亡率升高(P = 0.001)与 BSI 显著相关。相当一部分 BSI 为革兰氏阴性菌(n = 115),如鲍曼不动杆菌 38 例(33%)和肺炎克雷伯菌 30 例(26%)。在我们的研究中,血液中单微生物的比例较高,为 72 (72%)。对头孢他啶29(96.6%)、阿米卡星48(96%)、美罗培南48(96%)、头孢他啶47(94%)、环丙沙星46(92%)和奈替米星46(92%)的耐药性最高(50)。肺炎双球菌对头孢他啶 29(96.6%)、头孢唑肟 29(96.6%)、环丙沙星 22(73.3%)和头孢呋辛 21(70%)高度耐药。在革兰氏阳性菌中,肠球菌对庆大霉素和青霉素的耐药率为 66.6%:结论:CRP 升高、需要使用 MV、之前接触过抗菌药物以及在重症监护室停留时间较长都应引起临床医生对 BSI 的警惕。因此,我们的研究强调了 BSI 的相关风险因素,并强调要遵守医院感染控制政策和抗生素管理计划。
{"title":"Associated Risk Factors and Clinical Outcomes of Bloodstream Infections among COVID-19 Intensive Care Unit Patients in a Tertiary Care Hospital.","authors":"Mahalakshmamma Dasarahalli Shivalingappa, Supriya Gachinmath, Shiva Kumar Narayan","doi":"10.4103/jgid.jgid_108_23","DOIUrl":"10.4103/jgid.jgid_108_23","url":null,"abstract":"<p><strong>Introduction: </strong>The COVID-19 infection is an ongoing public health crisis causing millions of deaths worldwide. COVID-19 patients admitted to the intensive care unit (ICU) are more vulnerable to acquire secondary bloodstream infections (sBSIs) which cause a significant morbidity and mortality. Thus, we aim to assess the risk factors of sBSIs and outcomes in COVID-19 ICU patients.</p><p><strong>Methods: </strong>One hundred blood culture samples with growth (cases) and other 100 blood culture with no growth(controls) were collected.. All the demographic data, laboratory data and antimicrobial resistance pattern were analysed . Blood culture bottle received in the Microbiology laboratory were loaded into Automated blood culture system. Flagged bottles were processed for final identification by MALDI TOF and automated antibiotic susceptibility testing. Flagged bottles were processed for final identification by MALDI TOF and automated antibiotic susceptibility testing.</p><p><strong>Results: </strong>Raised C-reactive protein (CRP) (<i>P</i> = 0.0035), interleukin-6 (<i>P</i> = 0.0404), mechanical ventilation (MV) (<i>P</i> = 0.024), prior antimicrobial exposure (<i>P</i> = 0.002), longer ICU stay with median 11 days (<i>P</i> = 0.022), and higher mortality rate (<i>P</i> = 0.001) were significantly associated with the BSI. A significant proportion of BSIs were Gram-negative bacteria (<i>n</i> = 115) such as <i>Acinetobacter baumannii</i> 38 (33%) and <i>Klebsiella pneumoniae</i> 30 (26%). Monomicrobial organisms in blood yielded a higher proportion in our study 72 (72%). The highest resistance for <i>Acinetobacter</i> species (50) was observed with ceftazidime 29 (96.6%) amikacin 48 (96%), meropenem 48 (96%), cefotaxime 47 (94%), ciprofloxacin 46 (92%), and netilmicin 46 (92%). <i>K</i>. <i>pneumoniae</i> was highly resistant to cefotaxime 29 (96.6%), ceftazidime 29 (96.6%), ciprofloxacin 22 (73.3%), and cefuroxime 21 (70%). Among Gram-positive organisms, <i>Enterococcus</i> species showed that a resistance for high-level gentamicin and penicillin was 66.6%.</p><p><strong>Conclusions: </strong>Raised CRP, need of MV, prior antimicrobial exposure, and longer ICU stay should alarm clinicians for BSI. Hence, our study highlights the associated risk factors for BSI and emphasizes adherence to hospital infection control policies and antibiotic stewardship program.</p>","PeriodicalId":51581,"journal":{"name":"Journal of Global Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2024-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11286086/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141857106","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An Unusual Case of Pneumocystis jirovecii Cystic Pneumonia. 一个不寻常的肺孢子虫囊肿性肺炎病例
IF 1 Q4 INFECTIOUS DISEASES Pub Date : 2024-06-26 eCollection Date: 2024-04-01 DOI: 10.4103/jgid.jgid_33_24
Harpreet Singh, Deba Prasad Dhibhar, Vikas Suri, Ashish Bhalla
{"title":"An Unusual Case of <i>Pneumocystis jirovecii</i> Cystic Pneumonia.","authors":"Harpreet Singh, Deba Prasad Dhibhar, Vikas Suri, Ashish Bhalla","doi":"10.4103/jgid.jgid_33_24","DOIUrl":"10.4103/jgid.jgid_33_24","url":null,"abstract":"","PeriodicalId":51581,"journal":{"name":"Journal of Global Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2024-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11286083/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141857069","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Paradoxical Reaction during Treatment of Tuberculous Meningoencephalitis in a Patient with Systemic Lupus Erythematosus. 系统性红斑狼疮患者在治疗结核性脑膜脑炎期间出现的矛盾反应
IF 1 Q4 INFECTIOUS DISEASES Pub Date : 2024-06-26 eCollection Date: 2024-04-01 DOI: 10.4103/jgid.jgid_96_23
Isadora Lemos Versiani, Gabriela Flor Nimer, Carolina Braga Moura, Arthur Ferreira Xavier, Rodrigo Cutrim Gaudio, Fernanda Cristina Rueda Lopes, Caroline Bittar Braune

Tuberculous paradoxical reaction presents as clinical deterioration during appropriate tuberculosis therapy and is a separate entity from treatment failure and drug resistance. We describe a case of central nervous system paradoxical reaction following tuberculous meningoencephalitis treatment in an immunocompromised patient with systemic lupus erythematosus.

结核病矛盾反应是在适当的结核病治疗过程中出现的临床恶化,与治疗失败和耐药性是两个不同的实体。我们描述了一例患有系统性红斑狼疮的免疫功能低下患者在接受结核性脑膜脑炎治疗后出现中枢神经系统矛盾反应的病例。
{"title":"Paradoxical Reaction during Treatment of Tuberculous Meningoencephalitis in a Patient with Systemic Lupus Erythematosus.","authors":"Isadora Lemos Versiani, Gabriela Flor Nimer, Carolina Braga Moura, Arthur Ferreira Xavier, Rodrigo Cutrim Gaudio, Fernanda Cristina Rueda Lopes, Caroline Bittar Braune","doi":"10.4103/jgid.jgid_96_23","DOIUrl":"10.4103/jgid.jgid_96_23","url":null,"abstract":"<p><p>Tuberculous paradoxical reaction presents as clinical deterioration during appropriate tuberculosis therapy and is a separate entity from treatment failure and drug resistance. We describe a case of central nervous system paradoxical reaction following tuberculous meningoencephalitis treatment in an immunocompromised patient with systemic lupus erythematosus.</p>","PeriodicalId":51581,"journal":{"name":"Journal of Global Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2024-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11286087/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141857109","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Detection of Chlamydial Heat Shock Protein 60 and 10 Antibody among Female Infertility. 在女性不孕症患者中检测衣原体热休克蛋白 60 和 10 抗体
IF 1 Q4 INFECTIOUS DISEASES Pub Date : 2024-06-26 eCollection Date: 2024-04-01 DOI: 10.4103/jgid.jgid_147_23
Gopi Dhivya, Kopula Sathyamoorthy Sridharan, Sanjeeva Reddy Nellepalli, P Kennedy Kumar, Arunagiri Ramesh, Divya Katta

Introduction: Of the many sexually transmitted pathogens, Chlamydia trachomatis is increasingly being associated with long-term sequelae such as infertility, apart from causing genital tract infections. Many inflammatory responses directed against chlamydial infection can cause tubal damage resulting in infertility. For example, chlamydial heat shock protein 60 (cHSP60) and cHSP10 along with humoral immune response. The aim of our study is to detect the presence of immunoglobulin G (IgG) antibodies against Major Outer Membrane Protein (MOMP), cHSP60, and cHSP10 among female infertility.

Methods: A total number of 230 female infertility patients attending the Outpatient Department of Reproductive Medicine, SRIHER, were included in the study. Detailed history documented in the proforma. Serological detection of C. trachomatis IgG antibody against MOMP, cHSP60, and cHSP10 antibody was done by enzyme-linked immunosorbent assay (ELISA).

Results: C. trachomatis IgG antibody against MOMP was detected in 15 (6.5%) of 230 females. High seropositivity to cHSP60 antibodies was detected among females of tubal factor infertility (TFI). Our study showed that cHSP60 antibodies (3.4%) were more common than cHSP10 (2.6%).

Conclusion: Our study suggest cHSP60 or cHSP10 antibody detection by ELISA along with TFI is helpful for diagnosis and early institution of therapy. The accuracy of TFI prediction could be increased by the detection of anti-MOMP and cHSP60 over cHSP10 among secondary infertility than primary. The most probable reason for high seropositivity among secondary infertility patients may be due to repeated infection and chronicity because of longer active sexual life.

导言:在众多性传播病原体中,沙眼衣原体除了引起生殖道感染外,还越来越多地与不孕症等长期后遗症相关联。许多针对衣原体感染的炎症反应可造成输卵管损伤,导致不孕。例如,衣原体热休克蛋白 60(cHSP60)和 cHSP10 以及体液免疫反应。我们的研究旨在检测女性不孕症患者体内是否存在针对主要外膜蛋白(MOMP)、cHSP60 和 cHSP10 的免疫球蛋白 G(IgG)抗体:研究共纳入了 230 名在 SRIHER 生殖医学门诊部就诊的女性不孕症患者。在表格中详细记录病史。通过酶联免疫吸附试验(ELISA)检测沙眼衣原体 IgG 抗体对 MOMP、cHSP60 和 cHSP10 的抗体:结果:230 名女性中有 15 人(6.5%)检测到沙眼衣原体 MOMP IgG 抗体。在输卵管因素不孕(TFI)的女性中,cHSP60抗体的血清阳性率很高。我们的研究显示,cHSP60抗体(3.4%)比cHSP10(2.6%)更常见:我们的研究表明,通过 ELISA 检测 cHSP60 或 cHSP10 抗体以及 TFI 有助于诊断和早期治疗。与原发性不孕症相比,在继发性不孕症中检测抗MOMP和cHSP60抗体可提高TFI预测的准确性。继发性不孕症患者血清阳性率高的最大原因可能是反复感染和性生活活跃时间较长导致的慢性感染。
{"title":"Detection of Chlamydial Heat Shock Protein 60 and 10 Antibody among Female Infertility.","authors":"Gopi Dhivya, Kopula Sathyamoorthy Sridharan, Sanjeeva Reddy Nellepalli, P Kennedy Kumar, Arunagiri Ramesh, Divya Katta","doi":"10.4103/jgid.jgid_147_23","DOIUrl":"10.4103/jgid.jgid_147_23","url":null,"abstract":"<p><strong>Introduction: </strong>Of the many sexually transmitted pathogens, <i>Chlamydia trachomatis</i> is increasingly being associated with long-term sequelae such as infertility, apart from causing genital tract infections. Many inflammatory responses directed against chlamydial infection can cause tubal damage resulting in infertility. For example, chlamydial heat shock protein 60 (cHSP60) and cHSP10 along with humoral immune response. The aim of our study is to detect the presence of immunoglobulin G (IgG) antibodies against Major Outer Membrane Protein (MOMP), cHSP60, and cHSP10 among female infertility.</p><p><strong>Methods: </strong>A total number of 230 female infertility patients attending the Outpatient Department of Reproductive Medicine, SRIHER, were included in the study. Detailed history documented in the proforma. Serological detection of <i>C</i>. <i>trachomatis</i> IgG antibody against MOMP, cHSP60, and cHSP10 antibody was done by enzyme-linked immunosorbent assay (ELISA).</p><p><strong>Results: </strong><i>C</i>. <i>trachomatis</i> IgG antibody against MOMP was detected in 15 (6.5%) of 230 females. High seropositivity to cHSP60 antibodies was detected among females of tubal factor infertility (TFI). Our study showed that cHSP60 antibodies (3.4%) were more common than cHSP10 (2.6%).</p><p><strong>Conclusion: </strong>Our study suggest cHSP60 or cHSP10 antibody detection by ELISA along with TFI is helpful for diagnosis and early institution of therapy. The accuracy of TFI prediction could be increased by the detection of anti-MOMP and cHSP60 over cHSP10 among secondary infertility than primary. The most probable reason for high seropositivity among secondary infertility patients may be due to repeated infection and chronicity because of longer active sexual life.</p>","PeriodicalId":51581,"journal":{"name":"Journal of Global Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2024-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11286079/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141857107","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
State of the Globe: A Glimmer of Hope - Biomarkers for Diagnosing COVID-19 Pulmonary Fibrosis. 全球状况:一线希望--诊断 COVID-19 肺纤维化的生物标志物。
IF 1 Q4 INFECTIOUS DISEASES Pub Date : 2024-06-26 eCollection Date: 2024-04-01 DOI: 10.4103/jgid.jgid_119_24
Tanmoy Ghatak, Suman Thakur
{"title":"State of the Globe: A Glimmer of Hope - Biomarkers for Diagnosing COVID-19 Pulmonary Fibrosis.","authors":"Tanmoy Ghatak, Suman Thakur","doi":"10.4103/jgid.jgid_119_24","DOIUrl":"10.4103/jgid.jgid_119_24","url":null,"abstract":"","PeriodicalId":51581,"journal":{"name":"Journal of Global Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2024-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11286080/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141857110","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Diagnostic and Predictive Value of Biomarkers for Pulmonary Fibrosis in Patients with Coronavirus Disease 2019 2019年冠状病毒疾病患者肺纤维化生物标志物的诊断和预测价值
IF 1.6 Q2 Medicine Pub Date : 2024-05-24 DOI: 10.4103/jgid.jgid_150_23
Jiapei Lv, Liping Chen, Huaying Wang
In coronavirus disease 2019 (COVID-19), particularly in older people, dysregulated immune response and aberrant repair can result in varied severity secondary pulmonary fibrosis (PF). By detecting some indicators, the occurrence and prognosis of fibrosis can be measured, providing directions for COVID-19 treatment. The research study lasted for 3 months and involved 88 COVID-19 patients. According to the chest radiological examination, 47 (53.41%) individuals were found to have no PF, while 41 (46.59%) showed PF. Clinical data such as inflammation markers, imaging findings, blood gas analysis, and hospital stay length were collected. With area under the curve values of 0.7413, 0.7741, and 0.7048, respectively, and the study of the receiver operating characteristic curve demonstrated that mucin 1 (MUC1), carcinoembryonic antigen (CEA), and CXC chemokine receptor 10 (CXCL10) could diagnose the presence of COVID-19 PF. To evaluate the possibility of PF following severe acute respiratory syndrome coronavirus-2 infection, we established particular values for MUC1, CEA, and CXCL10 (1.296 ng/ml, 4.315 ng/ml, and 32.77 ng/ml, respectively). The survival curve for hospital days indicated that the length of hospital stays positively correlated with these three factors (P < 0.01). Transforming growth factor-beta did not correlate significantly with the severity of COVID-19 or PF. The results of this study suggested that the MUC1, CEA, and CXCL10 can be employed to explore the severity of secondary PF in COVID-19.
在冠状病毒病 2019(COVID-19)中,尤其是在老年人中,免疫反应失调和异常修复可导致不同程度的继发性肺纤维化(PF)。通过检测一些指标,可以衡量肺纤维化的发生和预后,为COVID-19的治疗提供方向。 该研究历时3个月,共有88名COVID-19患者参与。胸部放射学检查结果显示,47例(53.41%)患者无肺纤维化,41例(46.59%)患者有肺纤维化。研究人员收集了炎症指标、影像学检查结果、血气分析和住院时间等临床数据。 曲线下面积值分别为 0.7413、0.7741 和 0.7048,接收者操作特征曲线研究表明,粘蛋白 1 (MUC1)、癌胚抗原 (CEA) 和 CXC 趋化因子受体 10 (CXCL10) 可以诊断 COVID-19 PF 的存在。为了评估严重急性呼吸综合征冠状病毒-2 感染后出现 PF 的可能性,我们确定了 MUC1、CEA 和 CXCL10 的特定值(分别为 1.296 ng/ml、4.315 ng/ml 和 32.77 ng/ml)。住院天数生存曲线显示,住院时间与这三个因子呈正相关(P < 0.01)。转化生长因子-β与 COVID-19 或 PF 的严重程度无明显相关性。 本研究结果表明,MUC1、CEA和CXCL10可用于探讨COVID-19继发性PF的严重程度。
{"title":"The Diagnostic and Predictive Value of Biomarkers for Pulmonary Fibrosis in Patients with Coronavirus Disease 2019","authors":"Jiapei Lv, Liping Chen, Huaying Wang","doi":"10.4103/jgid.jgid_150_23","DOIUrl":"https://doi.org/10.4103/jgid.jgid_150_23","url":null,"abstract":"\u0000 \u0000 \u0000 In coronavirus disease 2019 (COVID-19), particularly in older people, dysregulated immune response and aberrant repair can result in varied severity secondary pulmonary fibrosis (PF). By detecting some indicators, the occurrence and prognosis of fibrosis can be measured, providing directions for COVID-19 treatment.\u0000 \u0000 \u0000 \u0000 The research study lasted for 3 months and involved 88 COVID-19 patients. According to the chest radiological examination, 47 (53.41%) individuals were found to have no PF, while 41 (46.59%) showed PF. Clinical data such as inflammation markers, imaging findings, blood gas analysis, and hospital stay length were collected.\u0000 \u0000 \u0000 \u0000 With area under the curve values of 0.7413, 0.7741, and 0.7048, respectively, and the study of the receiver operating characteristic curve demonstrated that mucin 1 (MUC1), carcinoembryonic antigen (CEA), and CXC chemokine receptor 10 (CXCL10) could diagnose the presence of COVID-19 PF. To evaluate the possibility of PF following severe acute respiratory syndrome coronavirus-2 infection, we established particular values for MUC1, CEA, and CXCL10 (1.296 ng/ml, 4.315 ng/ml, and 32.77 ng/ml, respectively). The survival curve for hospital days indicated that the length of hospital stays positively correlated with these three factors (P < 0.01). Transforming growth factor-beta did not correlate significantly with the severity of COVID-19 or PF.\u0000 \u0000 \u0000 \u0000 The results of this study suggested that the MUC1, CEA, and CXCL10 can be employed to explore the severity of secondary PF in COVID-19.\u0000","PeriodicalId":51581,"journal":{"name":"Journal of Global Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":1.6,"publicationDate":"2024-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141099362","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mesenteric Panniculitis Secondary to Epstein-Barr virus. 继发于 Epstein-Barr 病毒的肠系膜泛发炎。
IF 1 Q4 INFECTIOUS DISEASES Pub Date : 2024-05-24 eCollection Date: 2024-04-01 DOI: 10.4103/jgid.jgid_209_23
Mansoor C Abdulla, Suma Mariam Jacob, Samah Saeed Al Zouabi, Amal Ibrahim Abdel Latif Mohamed
{"title":"Mesenteric Panniculitis Secondary to Epstein-Barr virus.","authors":"Mansoor C Abdulla, Suma Mariam Jacob, Samah Saeed Al Zouabi, Amal Ibrahim Abdel Latif Mohamed","doi":"10.4103/jgid.jgid_209_23","DOIUrl":"10.4103/jgid.jgid_209_23","url":null,"abstract":"","PeriodicalId":51581,"journal":{"name":"Journal of Global Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2024-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11286081/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141857108","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Purpura Fulminans: A Rare Manifestation of Indian Tick Typhus 富贵病紫癜:印度蜱斑疹伤寒的罕见表现
IF 1.6 Q2 Medicine Pub Date : 2024-05-24 DOI: 10.4103/jgid.jgid_56_24
Jayanth Kumar, S. Acharya, S. Shukla, Ashwini Tayade, Sunil Kumar
{"title":"Purpura Fulminans: A Rare Manifestation of Indian Tick Typhus","authors":"Jayanth Kumar, S. Acharya, S. Shukla, Ashwini Tayade, Sunil Kumar","doi":"10.4103/jgid.jgid_56_24","DOIUrl":"https://doi.org/10.4103/jgid.jgid_56_24","url":null,"abstract":"","PeriodicalId":51581,"journal":{"name":"Journal of Global Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":1.6,"publicationDate":"2024-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141098944","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence Rates of Tuberculosis, Human Immunodeficiency Virus, and Hepatitis B and C among Migrant Workers in Jordan 约旦移徙工人中结核病、人体免疫缺陷病毒、乙型肝炎和丙型肝炎的流行率
IF 1.6 Q2 Medicine Pub Date : 2024-05-24 DOI: 10.4103/jgid.jgid_104_23
Yousef Khader, Nathirah Warrad, Sudi Maiteh
Migration across national borders is an influential factor of consideration in the control of infectious diseases. Therefore, including migrants in surveillance and screening programs as well as linkage to care is mandatory to meet the public health targets of countries and regions. This study aimed to determine the prevalence of tuberculosis (TB), human immunodeficiency virus (HIV), hepatitis B virus (HBV), and hepatitis C virus (HCV) among migrant workers applying for work permits in Jordan during the period 2018–2020. The findings of this study are expected to guide health policy to prevent the spread of infectious diseases in Jordan. During the period 2018–2020, 439,622 migrant workers underwent routine testing for TB, HIV, and hepatitis B and C. Demographic, laboratory, and clinical data for those migrants were retrieved from the Directorate of Chest Diseases and Immigrants Health records. The overall prevalence of the mentioned diseases as well as by subgroups was calculated. The prevalence rates of TB and HIV among migrants were 54 per 100,000 migrants (11 per 100,000 male migrants and 138 per 100,000 female migrants, P < 0.001) and 21 per 100,000 (11 per 100,000 male migrants and 41 per 100,000 female migrants, P < 0.001), respectively. The prevalence of hepatitis B was 10 per 1000 migrants (12 per 1000 male migrants and 7 per 1000 female migrants, P < 0.001) and the prevalence of hepatitis C was 37 per 1000 (51 per 1000 male migrants and 10 per 1000 female migrants, P < 0.001). The prevalence of all studied conditions varied significantly according to gender, age, occupation, and country of origin. The prevalence rates of TB, HIV, HBV, and HCV were generally higher among migrants than Jordanians. Evidence-based health policies need to be drafted that aim to address migrant workers health care to ensure the lowest possible risk from infectious diseases to the people of Jordan is maintained. The study findings can inform the formulation of immigration and public health policies, including screening requirements for migrant workers, health insurance provisions, labor regulations, and support services for those with these conditions.
跨国移民是控制传染病的一个影响因素。因此,要实现国家和地区的公共卫生目标,就必须将移民纳入监测和筛查计划以及护理联系。本研究旨在确定 2018-2020 年期间在约旦申请工作许可的移民工人中结核病(TB)、人类免疫缺陷病毒(HIV)、乙型肝炎病毒(HBV)和丙型肝炎病毒(HCV)的流行情况。这项研究的结果有望为约旦预防传染病传播的卫生政策提供指导。 在 2018-2020 年期间,439,622 名移民工人接受了肺结核、艾滋病毒、乙型肝炎和丙型肝炎的常规检测。这些移民的人口统计、实验室和临床数据均来自胸病和移民健康局的记录。计算了上述疾病的总体流行率以及各分组的流行率。 肺结核和艾滋病毒在移民中的流行率分别为每 10 万移民中 54 例(每 10 万男性移民中 11 例,每 10 万女性移民中 138 例,P < 0.001)和每 10 万移民中 21 例(每 10 万男性移民中 11 例,每 10 万女性移民中 41 例,P < 0.001)。乙型肝炎的患病率为 10‰(男性移民为 12‰,女性移民为 7‰,P<0.001),丙型肝炎的患病率为 37‰(男性移民为 51‰,女性移民为 10‰,P<0.001)。所有研究病症的患病率因性别、年龄、职业和原籍国的不同而有显著差异。 移民中结核病、艾滋病毒、乙肝病毒和丙肝病毒的患病率普遍高于约旦人。需要起草以证据为基础的卫生政策,以解决移民工人的医疗保健问题,确保约旦人民尽可能降低感染传染病的风险。研究结果可为制定移民和公共卫生政策提供参考,包括对移民工人的筛查要求、医疗保险规定、劳动法规以及为患有这些疾病的人提供的支持服务。
{"title":"Prevalence Rates of Tuberculosis, Human Immunodeficiency Virus, and Hepatitis B and C among Migrant Workers in Jordan","authors":"Yousef Khader, Nathirah Warrad, Sudi Maiteh","doi":"10.4103/jgid.jgid_104_23","DOIUrl":"https://doi.org/10.4103/jgid.jgid_104_23","url":null,"abstract":"\u0000 \u0000 \u0000 Migration across national borders is an influential factor of consideration in the control of infectious diseases. Therefore, including migrants in surveillance and screening programs as well as linkage to care is mandatory to meet the public health targets of countries and regions. This study aimed to determine the prevalence of tuberculosis (TB), human immunodeficiency virus (HIV), hepatitis B virus (HBV), and hepatitis C virus (HCV) among migrant workers applying for work permits in Jordan during the period 2018–2020. The findings of this study are expected to guide health policy to prevent the spread of infectious diseases in Jordan.\u0000 \u0000 \u0000 \u0000 During the period 2018–2020, 439,622 migrant workers underwent routine testing for TB, HIV, and hepatitis B and C. Demographic, laboratory, and clinical data for those migrants were retrieved from the Directorate of Chest Diseases and Immigrants Health records. The overall prevalence of the mentioned diseases as well as by subgroups was calculated.\u0000 \u0000 \u0000 \u0000 The prevalence rates of TB and HIV among migrants were 54 per 100,000 migrants (11 per 100,000 male migrants and 138 per 100,000 female migrants, P < 0.001) and 21 per 100,000 (11 per 100,000 male migrants and 41 per 100,000 female migrants, P < 0.001), respectively. The prevalence of hepatitis B was 10 per 1000 migrants (12 per 1000 male migrants and 7 per 1000 female migrants, P < 0.001) and the prevalence of hepatitis C was 37 per 1000 (51 per 1000 male migrants and 10 per 1000 female migrants, P < 0.001). The prevalence of all studied conditions varied significantly according to gender, age, occupation, and country of origin.\u0000 \u0000 \u0000 \u0000 The prevalence rates of TB, HIV, HBV, and HCV were generally higher among migrants than Jordanians. Evidence-based health policies need to be drafted that aim to address migrant workers health care to ensure the lowest possible risk from infectious diseases to the people of Jordan is maintained. The study findings can inform the formulation of immigration and public health policies, including screening requirements for migrant workers, health insurance provisions, labor regulations, and support services for those with these conditions.\u0000","PeriodicalId":51581,"journal":{"name":"Journal of Global Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":1.6,"publicationDate":"2024-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141099810","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Rapid Point-of-care Fluorescence Imaging Device Helps Prevent Graft Rejection Post Modified Radical Mastectomy 快速床旁荧光成像设备有助于预防改良根治性乳房切除术后的移植物排斥反应
IF 1.6 Q2 Medicine Pub Date : 2024-05-24 DOI: 10.4103/jgid.jgid_148_23
S. Mirza, Aayush Gupta
Pathogenic bacteria in wounds impede successful skin grafting. However, their detection relies on culture methods, which delay confirmation by several days. Real-time fluorescence imaging detects bacteria, allowing for rapid assessment and documentation. We herein report a post modified radical mastectomy, surgical site infection with multidrug-resistant Pseudomonas spp. that underwent repeated antibiotic therapy and debridement and eventually grafting. In this case, a real-time fluorescence imaging device helped prevent graft rejection.
伤口中的致病细菌阻碍了植皮手术的成功。然而,对它们的检测依赖于培养方法,而这种方法会将确认时间推迟数天。实时荧光成像可检测细菌,从而进行快速评估和记录。我们在此报告了一起改良根治性乳房切除术后手术部位感染的病例,患者感染了耐多药的假单胞菌,经过反复抗生素治疗和清创,最终进行了植皮手术。在这个病例中,实时荧光成像设备帮助防止了移植排斥反应。
{"title":"A Rapid Point-of-care Fluorescence Imaging Device Helps Prevent Graft Rejection Post Modified Radical Mastectomy","authors":"S. Mirza, Aayush Gupta","doi":"10.4103/jgid.jgid_148_23","DOIUrl":"https://doi.org/10.4103/jgid.jgid_148_23","url":null,"abstract":"\u0000 Pathogenic bacteria in wounds impede successful skin grafting. However, their detection relies on culture methods, which delay confirmation by several days. Real-time fluorescence imaging detects bacteria, allowing for rapid assessment and documentation. We herein report a post modified radical mastectomy, surgical site infection with multidrug-resistant Pseudomonas spp. that underwent repeated antibiotic therapy and debridement and eventually grafting. In this case, a real-time fluorescence imaging device helped prevent graft rejection.","PeriodicalId":51581,"journal":{"name":"Journal of Global Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":1.6,"publicationDate":"2024-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141098682","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Global Infectious Diseases
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1